Shanghai Bio-heart Biological Technology Co (HKSE:02185) PB Ratio : 0.47 (As of Jan. 18, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Bio-heart Biological Technology Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-01-18), Shanghai Bio-heart Biological Technology Co's share price is HK$1.50. Shanghai Bio-heart Biological Technology Co's Book Value per Share for the quarter that ended in Jun. 2024 was HK$3.20. Hence, Shanghai Bio-heart Biological Technology Co's PB Ratio of today is 0.47.

The historical rank and industry rank for Shanghai Bio-heart Biological Technology Co's PB Ratio or its related term are showing as below:

HKSE:02185' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 14.95
Current: 0.47

During the past 5 years, Shanghai Bio-heart Biological Technology Co's highest PB Ratio was 14.95. The lowest was 0.00. And the median was 0.00.

HKSE:02185's PB Ratio is ranked better than
92.78% of 1288 companies
in the Biotechnology industry
Industry Median: 2.36 vs HKSE:02185: 0.47

During the past 12 months, Shanghai Bio-heart Biological Technology Co's average Book Value Per Share Growth Rate was -13.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -1.20% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Bio-heart Biological Technology Co was 183.20% per year. The lowest was -1.20% per year. And the median was 91.00% per year.

Back to Basics: PB Ratio

Shanghai Bio-heart Biological Technology Co PB Ratio Historical Data

The historical data trend for Shanghai Bio-heart Biological Technology Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Bio-heart Biological Technology Co PB Ratio Chart

Shanghai Bio-heart Biological Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

5.43

1.44

1.02

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
PB Ratio	Get a 7-Day Free Trial					13.44	1.44	1.26	1.02	0.58

Competitive Comparison of Shanghai Bio-heart Biological Technology Co's PB Ratio

For the Biotechnology subindustry, Shanghai Bio-heart Biological Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Bio-heart Biological Technology Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Bio-heart Biological Technology Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Bio-heart Biological Technology Co's PB Ratio falls into.

Shanghai Bio-heart Biological Technology Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shanghai Bio-heart Biological Technology Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2024)
	=	1.50	/	3.196
	=	0.47

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Shanghai Bio-heart Biological Technology Co (HKSE:02185) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Shanghai Bio-heart Biological Technology Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Bio-heart Biological Technology Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Bio-heart Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

http://www.bio-heart.com

Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.

Executives

Wang Nengguang	2201 Interest of corporation controlled by you
Magic Grace Limited	2101 Beneficial owner
Loft Success Investments Limited	2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii, L.p.	2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii Gp Limited	2201 Interest of corporation controlled by you
Lc Fund Gp Limited	2201 Interest of corporation controlled by you
Great Unity Fund I, L.p.	2201 Interest of corporation controlled by you
Chen Hao	2201 Interest of corporation controlled by you
Proud Solar Limited	2201 Interest of corporation controlled by you
Right Lane Limited	2201 Interest of corporation controlled by you
Sk China Company Limited	2201 Interest of corporation controlled by you
Union Season Holdings Limited	2201 Interest of corporation controlled by you
Zhu Linan	2201 Interest of corporation controlled by you
Lian Xiang Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you

Shanghai Bio-heart Biological Technology Co Headlines

No Headlines